Search Results for 'treatment hcv'

treatment hcv published presentations and documents on DocSlides.

HIV Prevention, treatment and care among

HIV Prevention, treatment and care among

by alexa-scheidler

people who inject drugs . Fabienne Hariga, MD, MP...

EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF

EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF

by hezekiah

FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...

Safety and Efficacy of Daclatasvir

Safety and Efficacy of Daclatasvir

by tabitha

. Plus . Sofosbuvir. With or Without Ribavirin . ...

World Hepatitis Day 28 July 202

World Hepatitis Day 28 July 202

by isabella2

1 Theme Bringinghepatitiscare closer to you SOC...

Practical management of PI therapy

Practical management of PI therapy

by TropicalParadise

in Hepatitis C . Paris . Februari. 2012. Ola . We...

Zero TB Karachi

Zero TB Karachi

by caroline

Targeting Multiple Diseases from a Single Disease ...

≥ 18 years, HCV genotype 1-6

≥ 18 years, HCV genotype 1-6

by karlyn-bohler

≥ 18 years, HCV genotype 1-6 HCV RNA > 1 00...

Access to medicines in Europe

Access to medicines in Europe

by trish-goza

Médecins du monde – Doctors of the World Inter...

CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE

CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE

by tawny-fly

ASSOC. PROF. DR. INGRID MIRON. What is Viral Hepa...

Ledipasvir-Sofosbuvir ( Harvoni

Ledipasvir-Sofosbuvir ( Harvoni

by sherrill-nordquist

). Slide deck prepared . by: . David H. Spach, MD...

Chronic hepatitis C: guidelines for screening and

Chronic hepatitis C: guidelines for screening and

by aaron

treatment. Lisa M. Glass, MD. Clinical Lecturer. ...

by alexa-scheidler

HEPATITIS. Hepatitis. -Is inflammation of the liv...

by olivia-moreira

. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...

State of the Art Therapy for HCV

State of the Art Therapy for HCV

by liane-varnes

Last Updated: February . 21, 2014. Robert G. Gish...

Access to medicines in Europe

Access to medicines in Europe

by cheryl-pisano

Médecins du monde – Doctors of the World Inter...

Access to medicines in Europe

Access to medicines in Europe

by pamella-moone

Médecins du monde – Doctors of the World Inter...

by min-jolicoeur

Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...

by ellena-manuel

Morris Sherman MD . BCh. PhD FRCP(C) . Associate...

by marina-yarberry

Foundation for Faith Based Organizations. www.NYC...

Treatment of Chronic Hepatitis C Virus Infection

Treatment of Chronic Hepatitis C Virus Infection

by celsa-spraggs

Treatment of Chronic Hepatitis C Virus Infection i...

Key Updates from 2023 Conference on Retroviruses and Opportunistic Infections (CROI)

Key Updates from 2023 Conference on Retroviruses and Opportunistic Infections (CROI)

by josephine

Jeffrey Lennox, MD. Professor of Medicine. Emory U...

3D (Paritaprevir-Ritonavir-

3D (Paritaprevir-Ritonavir-

by ava

Ombitasvir + . Dasabuvir) +/- . RBV in . GT1b. PEA...

Insight into the history

Insight into the history

by elizabeth

of hepatitis C virus (HCV. ) infection; . a cohort...

Webinar presented by : ANDES

Webinar presented by : ANDES

by teresa

Prediction. . of . events. . after. ART. initia...

CAHR 2019 Scientific summary of the major clinical studies presented at the 28th Annual Canadian Co

CAHR 2019 Scientific summary of the major clinical studies presented at the 28th Annual Canadian Co

by osullivan

Résumé scientifique des principales études clin...

NS5A and polymerase inhibitors

NS5A and polymerase inhibitors

by LoveBug

Mark Sulkowski, MD. Professor of Medicine. Johns H...

Are (exogenous) interferons

Are (exogenous) interferons

by amey

really necessary?. Peter . Ferenci. Medical Univer...

Tobacco Free Villages A Leap forward for Tobacco free Punjab

Tobacco Free Villages A Leap forward for Tobacco free Punjab

by cappi

4. th. National Summit on Good and Replicable Pr...

Best of Digital ILC 2020

Best of Digital ILC 2020

by jordyn

Viral hepatitis. About these slides. These slides ...

Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir

Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir

by vamput

Prepared by: . Sophie . Woolston. , MD and David H...

Liver tumours Best of ILC 2018

Liver tumours Best of ILC 2018

by min-jolicoeur

About these slides. These slides provide highligh...

Efficacy and Safety of

Efficacy and Safety of

by olivia-moreira

Efficacy and Safety of Glecaprevir / Pibrentasvi...

History of Viral Hepatitis and Liver

History of Viral Hepatitis and Liver

by ellena-manuel

Disease . in Alaska. Brian J McMahon. Medical Dir...

Liver tumours Best of ILC 2018

Liver tumours Best of ILC 2018

by karlyn-bohler

About these slides. These slides provide highligh...

Cost-Effectiveness of a One-Time National Hepatitis C Screening Program:

Cost-Effectiveness of a One-Time National Hepatitis C Screening Program:

by phoebe-click

Impact . of a Selective Drug Reimbursement Policy...

Updated Guidelines for Managing HIV/HCV Co-Infection

Updated Guidelines for Managing HIV/HCV Co-Infection

by karlyn-bohler

John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...

The Immune Response of

The Immune Response of

by alexa-scheidler

Prolactin. . and the . Induction . of . Tumor Ne...

Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N

Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N

by debby-jeon

Guidelines for Prevention and Treatment of Opport...

Treatment of HCV Coinfection

Treatment of HCV Coinfection

by test

:. Navigating the Interactions. Jennifer J. Kiser...

Nonalcoholic Fatty Liver Disease [NAFLD]

Nonalcoholic Fatty Liver Disease [NAFLD]

by phoebe-click

Masi. . Khaja. , M.D. Objectives . Epidemiology....